Influence of regulatory T cells on antitumor activity of dendritic cells-cytokine induced killer cells in gastric cancer xenograft models
Shao Chun-yue
Abstract
Shao Chun-yue
Abstract
Objective:To investigate the in vivo anti-tumor effect of CD4+CD25+ regulatory T cells on dendritic cells-cytokine induced killer cells(DC-CIK) from peripheral blood in gastric cancer xenograft model.Methods: The BALB/c nude mice inoculated with gastric cancer cell line SGC-7901 were used as animal model.Peripheral blood mononuclear cells were isolated from healthy human.The experiment were divided into two groups: DC-CIK cells group(conventional mononuclear cells were induced to DC-CIK cells) and DC-CIK-Treg/del cells group(the peripheral mononuclear cells depleting CD4+ CD25 + regulatory T cell by+ immunomagnetic beads sorting were induced to DC-CIK cells).The cells phenotype were detected with flow cytometry;the antitumor activity of the DC-CIK cells in vivo were evaluated in BALB/c nude mice.Results: The cell proliferation of DC-CIK-Treg/del group is higher than the DC-CIK group,The levels of CD3+CD56+ were significantly increased in DC-CIK-Treg/del group after 15 days in DC-CIK culture(P0.05);DC-CIK cells had a stronger suppressive effect on tumor growth in nude mice bearing subcutaneous in vivo.The infusion of DC-CIK cells inhibited the growth of tumor cells inoculated in the mice.The tumor inhibition was significantly higher in the DC-CIK-Treg/del group than the DC-CIK group(P0.05).Conclusion: DC-CIK cells are immunocompetent cells which have a stronger suppression against growth of tumor in vivo.CD4+ CD25 + regulatory T cell with immunosuppressive fuction in DC-CIK cells could reduce the antitumor effect and removal of CD4+ CD25 + regulatory T cell could enhance the body's anti-tumor effect,which provide a practical method for the effective immunotherapy of tumor.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the in vivo anti-tumor effect of CD4+CD25+ regulatory T cells on dendritic cells-cytokine induced killer cells(DC-CIK) from peripheral blood in gastric cancer xenograft model.Methods: The BALB/c nude mice inoculated with gastric cancer cell line SGC-7901 were used as animal model.Peripheral blood mononuclear cells were isolated from healthy human.The experiment were divided into two groups: DC-CIK cells group(conventional mononuclear cells were induced to DC-CIK cells) and DC-CIK-Treg/del cells group(the peripheral mononuclear cells depleting CD4+ CD25 + regulatory T cell by+ immunomagnetic beads sorting were induced to DC-CIK cells).The cells phenotype were detected with flow cytometry;the antitumor activity of the DC-CIK cells in vivo were evaluated in BALB/c nude mice.Results: The cell proliferation of DC-CIK-Treg/del group is higher than the DC-CIK group,The levels of CD3+CD56+ were significantly increased in DC-CIK-Treg/del group after 15 days in DC-CIK culture(P0.05);DC-CIK cells had a stronger suppressive effect on tumor growth in nude mice bearing subcutaneous in vivo.The infusion of DC-CIK cells inhibited the growth of tumor cells inoculated in the mice.The tumor inhibition was significantly higher in the DC-CIK-Treg/del group than the DC-CIK group(P0.05).Conclusion: DC-CIK cells are immunocompetent cells which have a stronger suppression against growth of tumor in vivo.CD4+ CD25 + regulatory T cell with immunosuppressive fuction in DC-CIK cells could reduce the antitumor effect and removal of CD4+ CD25 + regulatory T cell could enhance the body's anti-tumor effect,which provide a practical method for the effective immunotherapy of tumor.
Key concepts: Cytokine-induced killer cell, Peripheral blood mononuclear cell, IL-2 receptor, In vivo, Flow cytometry, Cancer research, Dendritic cell, Immunology